Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Bristol Myers Squibb Co (BMY)

2014-04-18@00:59:11 ET
FluoroPharma Names Dr. H. William Strauss to Chair the Scientific Advisory Board (CLM)

2014-04-17@12:02:03 ET
Bristol-Myers Squibb Bullish Moving Average Crossover Alert (BMY) (F78)

2014-04-17@11:30:00 ET
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE (PRN)

2014-04-17@00:36:00 ET
Bristol-Myers Squibb Reports Submission of New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1 (CLM)

2014-04-16@13:28:23 ET
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $48.61 (F79)

2014-04-16@12:42:24 ET
Shares of Bristol-Myers Squibb Receive a Boost, Up 1.3% (F77)

2014-04-16@11:14:57 ET
Bristol-Myers Squibb (BMY) Crosses Pivot Point Resistance at $48.61 (PSM)

2014-04-16@07:11:09 ET
Bristol-Myers Seeks Approval for HIV Combo Drug (ZAX)

2014-04-16@05:31:30 ET
Research and Markets: Global Testicular Cancer Drugs Market 2014-2018 With Bristol-Myers Squibb, Hospira, Teva Pharmaceutical Industries & ZIOPHARM Oncology Dominating (BIZ)

2014-04-16@05:24:29 ET
DKSH and Bristol-Myers Squibb extend regional agreement in six Asian markets (DTM)

2014-04-16@05:22:49 ET
Bristol-Myers announces encouraging results from Phase III hepatitis C study (DTM)

2014-04-16@04:35:37 ET
Global Testicular Cancer Drugs Market 2014-2018 with Bristol-Myers Squibb, Hospira, Teva Pharmaceutical Industries & ZIOPHARM Oncology Dominating (MTO)

2014-04-15@08:30:28 ET
Bottom 5 Companies in the Pharmaceuticals Industry with the Lowest Relative Performance (FLML, QCOR, MDCO, BMY, VRX) (F70)

2014-04-14@16:44:38 ET
SmarTrend Watching for Potential Rebound in Shares of Bristol-Myers Squibb After 1.78% Loss (PSM)

2014-04-14@16:44:07 ET
SmarTrend Watching for Potential Rebound in Shares of Bristol-Myers Squibb After 1.78% Loss (PSM)

2014-04-14@14:57:09 ET
Bristol Myers (BMY) Trading Near $48.29 Support Level (FBM)

2014-04-14@08:01:49 ET
Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1 (BIZ)

2014-04-14@07:27:39 ET
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board (INW)

2014-04-14@00:09:18 ET
Bristol-Myers Squibb Highlights Phase III Data Demonstrates that Investigational All-oral Daclatasvir and Asunaprevir Therapy Achieved SVR12 Rates of up to 90 percent Among Broad Range of Genotype 1b Hepatitis C Patients (CLM)

2014-04-11@08:56:13 ET
Bristol Myers (BMY) Showing Resistance Near $51.17 (FBM)